Global Markets
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
FTSE

FTSE 100 Trades Slightly Lower

The FTSE 100 edged lower on Monday as investors assessed renewed tensions in the Middle East after the US and Iran exchanged fresh airstrikes over the weekend. Tehran claimed it had closed the Strait of Hormuz after targeting US facilities across several Gulf states, although President Donald Trump rejected the assertion, saying the key shipping route remained open to commercial traffic. Energy stocks outperformed as higher oil prices lifted Shell by 1.4% and BP by 2.5%, but gains were offset by broad weakness across the rest of the market. Mining shares came under pressure, with Endeavour down nearly 2%, Fresnillo falling 1.4%, Antofagasta losing 1.8%, and Anglo American slipping 0.8%. Financial stocks also declined, with Standard Chartered and Barclays down around 1%, while HSBC and Lloyds Banking traded lower. Elsewhere, GSK gained 0.9% after reporting positive interim trial results for its cancer drug Jemperli.

Register a Revolut Business Account

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button